The number of people with susceptibility test result for rifampicin in Marshall Islands
Marshall Islands: The number of people with susceptibility test result for rifampicin was 31 in 2021. ▼ Falling
Latest (2021)
31
Change on year
up 55.0%
World rank
127th
of 155 countries
All-time high
67
in 2017
All-time low
20
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Marshall Islands, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Marshall Islands recorded 31 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 55.0% on the previous year and down 53.7% over five years.
That places Marshall Islands 127th out of 155 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 67 | — |
| 2018 | 65 | -3.0% |
| 2019 | 30 | -53.8% |
| 2020 | 20 | -33.3% |
| 2021 | 31 | +55.0% |
Marshall Islands compared with similar countries
- Marshall Islands's 31 is below the median for upper middle income countries, which is 880, 4% of the median. (46 countries reporting)
- Marshall Islands's 31 is below the median for East Asia & Pacific, which is 185, 17% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 54 | 30 | 67 | 3 |
| 2020s | 25.5 | 20 | 31 | 2 |
Countries ranked near Marshall Islands
More health data for Marshall Islands
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -7.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0494 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.43 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Marshall Islands?
- The number of people with susceptibility test result for rifampicin in Marshall Islands was 31 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Marshall Islands?
- The highest recorded value was 67 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Marshall Islands?
- The lowest recorded value was 20 in 2020.
- How does Marshall Islands rank for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 127th out of 155 countries with data for 2021.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).